MYMD PHARMACEUTICALS INC (MYMD) Stock Price & Overview
NASDAQ:MYMD • US62856X2018
Current stock price
The current stock price of MYMD is 1.82 USD. Today MYMD is down by 0%. In the past month the price decreased by -2.15%. In the past year, price decreased by -94.48%.
MYMD Key Statistics
- Market Cap
- 4.204M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.18
- Dividend Yield
- N/A
MYMD Stock Performance
MYMD Stock Chart
MYMD Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to MYMD. When comparing the yearly performance of all stocks, MYMD is a bad performer in the overall market: 97.64% of all stocks are doing better.
MYMD Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to MYMD. MYMD scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
MYMD Earnings
MYMD Forecast & Estimates
MYMD Groups
Sector & Classification
MYMD Financial Highlights
Over the last trailing twelve months MYMD reported a non-GAAP Earnings per Share(EPS) of -0.18. The EPS increased by 52.63% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -32.43% | ||
| ROE | -43.95% | ||
| Debt/Equity | 0 |
MYMD Ownership
MYMD Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 26.31 | 869.14B | ||
| JNJ | JOHNSON & JOHNSON | 18.19 | 555.642B | ||
| MRK | MERCK & CO. INC. | 23 | 289.223B | ||
| PFE | PFIZER INC | 9.21 | 156.544B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 9.34 | 120.728B | ||
| ZTS | ZOETIS INC | 17.35 | 51.606B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 9.54 | 28.443B | ||
| VTRS | VIATRIS INC | 5.96 | 17.315B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 22.51 | 11.825B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 9.651B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 6.206B | ||
| TERN | TERNS PHARMACEUTICALS INC | N/A | 6.087B | ||
| CORT | CORCEPT THERAPEUTICS INC | 85.4 | 4.929B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About MYMD
Company Profile
MyMD Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company, which engages in the development of drug products targeting aging, age-related, and autoimmune diseases, chronic pain, anxiety, and sleep disorders. The company is headquartered in Baltimore, Maryland and currently employs 9 full-time employees. The company went IPO on 2008-07-24. The firm is focused on developing two novel therapeutic platforms that treat the causes of disease rather than only addressing the symptoms. The Company’s MYMD-1 is a drug platform based on a clinical-stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines. MYMD-1 is being developed to delay aging, increase longevity, and treat autoimmune diseases. The company also shows potential as an anti-fibrotic and anti-prolific therapeutic. The Company’s second drug platform, Supera-CBD, is being developed to treat chronic pain, addiction, and epilepsy. Supera-CBD is a synthetic, preclinical cannabidiol derivative that has been demonstrated to effectively target cannabinoid type 2 (CB2) receptors. Supera-CBD binds to and inhibits opioid receptors, comparing it side by side with plant-based cannabidiol (CBD).
Company Info
IPO: 2008-07-24
MYMD PHARMACEUTICALS INC
855 N. Wolfe Street, Suite 601
Baltimore MARYLAND 08086 US
CEO: Christopher C. Schreiber
Employees: 9
Phone: 18568488698
MYMD PHARMACEUTICALS INC / MYMD FAQ
What does MYMD PHARMACEUTICALS INC do?
MyMD Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company, which engages in the development of drug products targeting aging, age-related, and autoimmune diseases, chronic pain, anxiety, and sleep disorders. The company is headquartered in Baltimore, Maryland and currently employs 9 full-time employees. The company went IPO on 2008-07-24. The firm is focused on developing two novel therapeutic platforms that treat the causes of disease rather than only addressing the symptoms. The Company’s MYMD-1 is a drug platform based on a clinical-stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines. MYMD-1 is being developed to delay aging, increase longevity, and treat autoimmune diseases. The company also shows potential as an anti-fibrotic and anti-prolific therapeutic. The Company’s second drug platform, Supera-CBD, is being developed to treat chronic pain, addiction, and epilepsy. Supera-CBD is a synthetic, preclinical cannabidiol derivative that has been demonstrated to effectively target cannabinoid type 2 (CB2) receptors. Supera-CBD binds to and inhibits opioid receptors, comparing it side by side with plant-based cannabidiol (CBD).
What is the current price of MYMD stock?
The current stock price of MYMD is 1.82 USD.
What is the dividend status of MYMD PHARMACEUTICALS INC?
MYMD does not pay a dividend.
What is the ChartMill technical and fundamental rating of MYMD stock?
MYMD has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Which stock exchange lists MYMD stock?
MYMD stock is listed on the Nasdaq exchange.
Can you provide the upcoming earnings date for MYMD PHARMACEUTICALS INC?
MYMD PHARMACEUTICALS INC (MYMD) will report earnings on 2024-08-12, after the market close.
Can you provide the ownership details for MYMD stock?
You can find the ownership structure of MYMD PHARMACEUTICALS INC (MYMD) on the Ownership tab.